Clinical Trial

Scientific Content Disseminated Via Social Media for Physiotherapists

Study acronym: ASTEROID
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is designed to assess how effective social media is in disseminating scientific knowledge to physiotherapists in Brazil. The trial will include physiotherapists who treat at least three patients weekly and regularly use Instagram and WhatsApp. Participants will be randomly assigned to one of two groups: the experimental group will receive scientific content through Instagram, while the control group will receive the same content via email. Both groups will engage with the material for 10 weeks. The scientific content covers seven key topics related to physiotherapy, such as musculoskeletal and sport rehabilitation, and will be tailored to clinical practice. For the Instagram group, content will be shared via posts, stories, and reels, while the email group will receive summaries and links to full articles. The study aims to evaluate the impact of these interventions on participants\' engagement with scientific content and its application to clinical practice. Key outcomes will include the effectiveness of knowledge dissemination, participant feedback on the audiovisual content, and qualitative insights from interviews. The study will follow a specific timeline, with reassessment three months after the intervention to gauge long-term effects. Data will be analyzed using both quantitative and qualitative methods, ensuring a comprehensive understanding of the intervention\'s reach and feasibility.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-17.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-04-04
Trial Details
NCT Number NCT06605040
Lead Sponsor Universidade Federal de Santa Maria
Conditions Physiotherapy
Enrollment 120 participants
Start Date 2024-11-01
Primary Completion 2025-06 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2025-04-08